Should Investors Buy the Pullback in Rocket Lab Stock (RKLB)? Here's Wall Street's Take

Rocket Lab (RKLB) stock has declined more than 18% over the past month due to profit-taking, insider selling, SpaceX’s IPO excitement, and concerns about space stocks after a Blue Origin explosion. Still, RKLB is up 54% year-to-date. Analysts broadly remain bullish, with KeyBanc upgrading RKLB to Buy and a $135 target, calling it a clear #2 to SpaceX and citing Electron's launch history and Neutron progress. Cantor Fitzgerald also backs a Buy, noting Nasdaq-100 inclusion on June 22 and RKLB’s diversified rocket lineup (Electron, HASTE, Neutron) and geography. Wells Fargo keeps a Hold on RKLB, citing Neutron delays and large projected 2026-27 spending.